Column Group LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001833486 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 13, 2026

Total Value: $82.79M (100.0% shares, 0.0% debt)

Holdings (5)

— Surrozen, Inc. 50.5%

Value $41.84M Shares 1,851,350 Est. Cost $12.06 Unrealized —

ORIC ORIC Pharmaceuticals Inc. 35.0%

Value $28.96M Shares 3,540,777 Est. Cost $28.69 Unrealized -59.9%

TNYA Tenaya Therapeutics, Inc. 8.1%

Value $6.693M Shares 9,400,290 Est. Cost $21.49 Unrealized -93.7%

— RAPT Therapeutics Inc 6.4%

Value $5.293M Shares 156,270 Est. Cost $19.03 Unrealized —

RVMD Revolution Medicines Inc 0.0%

Value $3,664 Shares 46 Est. Cost $34.24 Unrealized +91.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Surrozen, Inc.	1,851,350	$41.84M	50.5%	$12.06	—	COM	86889P109
ORIC	ORIC Pharmaceuticals Inc.	3,540,777	$28.96M	35.0%	$28.69	-59.9%	COM	68622P109
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$6.693M	8.1%	$21.49	-93.7%	COM	87990A106
—	RAPT Therapeutics Inc	156,270	$5.293M	6.4%	$19.03	—	COM	75382E109
RVMD	Revolution Medicines Inc	46	$3,664	0.0%	$34.24	+91.5%	COM	76155X100